This Medical Affairs webinar assembles leading biopharma industry experts to discuss preparing your organization for digital transformation.
In partnership with experts from Open Health and Janssen EMEA, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training.
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.
The Series Podcast Objectives are:
Podcast objectives include understanding how the medical affairs strategic planning process can drive decision making throughout the year
The Medical Affairs Professional Society (MAPS) is honored to announce the inclusion of Johnson and Johnson Pharmaceuticals (JNJ) in the MAPS Industry Partnership Program
Amgen’s Victoria Elegant and Ka Weng Mah had front row seats to the start of COVID-19 in Asia. Here is what they learned about the future of Medical Affairs.
Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.
Q&A with Medical Affairs thought leaders describing changes in Digital and Field Medical during the pandemic and beyond
Nothing could stand between Joseph Eid and his dream of becoming a doctor—not even gunfire.
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.